Lakewood-Amedex Biotherapeutics
$0.2000
5
-$0.04-16.67%Friday 20:00
-$0.02-10%Friday 23:59After hours
Statistics
Day High
0.2043
Day Low
0.2043
52W High
98.2
52W Low
0.195
Volume
2,000
Avg. Volume
-
Mkt Cap
473,937.6
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 2Expected
Q2 2026
Next
-2.71
-2.25
-1.79
-1.33
Expected EPS
-1.33
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-923,000Net Income
Analyst Ratings
$3.00Average Price Target
The highest estimate is 3.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow LABT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
Show More
CEO
Kelvin Cooper
Employees
5
Country
United States
ISIN
US51255A2015
Listings
0 Comments
Share your thoughts
FAQs
What is Lakewood-Amedex Biotherapeutics stock price today?▼
The current price of LABT is $0.20 USD — it has decreased by -16.67% in the past 24 hours. Watch Lakewood-Amedex Biotherapeutics stock price performance more closely on the chart.
What is Lakewood-Amedex Biotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Lakewood-Amedex Biotherapeutics stocks are traded under the ticker LABT.
What is Lakewood-Amedex Biotherapeutics market cap?▼
Today Lakewood-Amedex Biotherapeutics has the market capitalization of 473,937.6
When is the next Lakewood-Amedex Biotherapeutics earnings date?▼
Lakewood-Amedex Biotherapeutics is going to release the next earnings report on December 2, 2026.
What were Lakewood-Amedex Biotherapeutics earnings last quarter?▼
LABT earnings for the last quarter are -2.71 USD per share, whereas the estimation was -2.66 USD resulting in a -1.69% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lakewood-Amedex Biotherapeutics revenue for the last year?▼
Lakewood-Amedex Biotherapeutics revenue for the last year amounts to 0 USD.
What is Lakewood-Amedex Biotherapeutics net income for the last year?▼
LABT net income for the last year is -923,000 USD.
How many employees does Lakewood-Amedex Biotherapeutics have?▼
As of November 1, 2026, the company has 5 employees.
In which sector is Lakewood-Amedex Biotherapeutics located?▼
Lakewood-Amedex Biotherapeutics operates in the Health & Wellness sector.
When did Lakewood-Amedex Biotherapeutics complete a stock split?▼
The last stock split for Lakewood-Amedex Biotherapeutics was on June 22, 2026 with a ratio of 1:10.
Where is Lakewood-Amedex Biotherapeutics headquartered?▼
Lakewood-Amedex Biotherapeutics is headquartered in UNIVERSITY PARK, United States.